In metabolic disorders such as obesity and type 2 diabetes (T2D), high levels of FGF21 are thought to represent compensatory responses to maintain metabolic homeostasis, which also represents its resistant state15,16. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.